(Q39043383)

8 September 2017

title

Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells (English)

1 reference

8 September 2017

1 reference

Amanda R Wasylishen

5

0 references

Linda Z Penn

Linda Z Penn

11

0 references

Paul C. Boutros

Paul C Boutros

10

0 references

James W Clendening

6

James W Clendening

1 reference

8 September 2017

9

Richard Lehner

1 reference

8 September 2017

Michelle Chan-Seng-Yue

2

Michelle Chan-Seng-Yue

1 reference

8 September 2017

7

Dorota H S Sendorek

1 reference

8 September 2017

3

Peter J Mullen

1 reference

8 September 2017

1

Carolyn A Goard

1 reference

8 September 2017

Ariel D Quiroga

4

1 reference

8 September 2017

Syed Haider

8

1 reference

8 September 2017

language of work or name

English

0 references

publication date

17 December 2013

1 reference

Breast Cancer Research and Treatment

8 September 2017

published in

1 reference

8 September 2017

volume

143

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

301-312

1 reference

Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Quantifying factors for the success of stratified medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Targeting tumor cell metabolism with statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Pharmacological actions of statins: a critical appraisal in the management of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Regulation of the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Breast cancer growth prevention by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Dysregulation of the mevalonate pathway promotes transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Systematic identification of genomic markers of drug sensitivity in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Subtype and pathway specific responses to anticancer compounds in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

MYC on the path to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Regulation of gene transcription by the oncoprotein MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

21 January 2018

c-Myc in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Direct multiplexed measurement of gene expression with color-coded probe pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Dissecting the heterogeneity of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2800-Y

10.1007/S10549-013-2800-Y

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference